Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1962 1
1968 1
1969 1
1970 1
1972 3
1973 5
1974 5
1975 6
1976 6
1977 8
1978 7
1979 8
1980 6
1981 10
1982 12
1983 12
1984 16
1985 10
1986 8
1987 15
1988 9
1989 5
1990 10
1991 6
1992 7
1993 10
1994 6
1995 13
1996 12
1997 16
1998 18
1999 5
2000 9
2001 12
2002 14
2003 11
2004 12
2005 12
2006 6
2007 14
2008 9
2009 9
2010 11
2011 10
2012 9
2013 15
2014 9
2015 15
2016 19
2017 22
2018 17
2019 16
2020 20
2021 16
2022 13
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

551 results

Results by year

Filters applied: . Clear all
Page 1
A microbiome-dependent gut-brain pathway regulates motivation for exercise.
Dohnalová L, Lundgren P, Carty JRE, Goldstein N, Wenski SL, Nanudorn P, Thiengmag S, Huang KP, Litichevskiy L, Descamps HC, Chellappa K, Glassman A, Kessler S, Kim J, Cox TO, Dmitrieva-Posocco O, Wong AC, Allman EL, Ghosh S, Sharma N, Sengupta K, Cornes B, Dean N, Churchill GA, Khurana TS, Sellmyer MA, FitzGerald GA, Patterson AD, Baur JA, Alhadeff AL, Helfrich EJN, Levy M, Betley JN, Thaiss CA. Dohnalová L, et al. Among authors: glassman a. Nature. 2022 Dec;612(7941):739-747. doi: 10.1038/s41586-022-05525-z. Epub 2022 Dec 14. Nature. 2022. PMID: 36517598
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. Among authors: glassman ar. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. Among authors: glassman ar. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Gross JG, Glassman AR, Liu D, Sun JK, Antoszyk AN, Baker CW, Bressler NM, Elman MJ, Ferris FL 3rd, Gardner TW, Jampol LM, Martin DF, Melia M, Stockdale CR, Beck RW; Diabetic Retinopathy Clinical Research Network. Gross JG, et al. Among authors: glassman ar. JAMA Ophthalmol. 2018 Oct 1;136(10):1138-1148. doi: 10.1001/jamaophthalmol.2018.3255. JAMA Ophthalmol. 2018. PMID: 30043039 Free PMC article. Clinical Trial.
Reply.
Wells JA, Glassman AR, Ayala AR, Jampol LM. Wells JA, et al. Among authors: glassman ar. Ophthalmology. 2017 Jan;124(1):e5-e6. doi: 10.1016/j.ophtha.2016.04.032. Ophthalmology. 2017. PMID: 27993277 Free PMC article. No abstract available.
Reply.
Bressler SB, Beaulieu WT, Glassman AR. Bressler SB, et al. Among authors: glassman ar. Ophthalmology. 2017 Dec;124(12):e88-e89. doi: 10.1016/j.ophtha.2017.06.026. Ophthalmology. 2017. PMID: 29157436 No abstract available.
Reply.
Wells JA, Glassman AR, Bressler NM, Ayala AR, Jampol LM. Wells JA, et al. Among authors: glassman ar. Ophthalmology. 2017 Apr;124(4):e38-e39. doi: 10.1016/j.ophtha.2016.08.032. Ophthalmology. 2017. PMID: 28335949 No abstract available.
Reply.
Wells JA, Glassman AR, Jampol LM, Ayala A, Bressler NM. Wells JA, et al. Among authors: glassman ar. Ophthalmology. 2017 Mar;124(3):e26-e27. doi: 10.1016/j.ophtha.2016.07.001. Ophthalmology. 2017. PMID: 28219510 No abstract available.
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
Wells JA, Glassman AR, Ayala AR, Jampol LM, Bressler NM, Bressler SB, Brucker AJ, Ferris FL, Hampton GR, Jhaveri C, Melia M, Beck RW; Diabetic Retinopathy Clinical Research Network. Wells JA, et al. Among authors: glassman ar. Ophthalmology. 2016 Jun;123(6):1351-9. doi: 10.1016/j.ophtha.2016.02.022. Epub 2016 Feb 27. Ophthalmology. 2016. PMID: 26935357 Free PMC article. Clinical Trial.
551 results